06-01-2021

A new study sheds light on the prevalence and impact of vitamin D deficiency in critically ill cancer patients.

Vitamin D deficiency is common among cancer patients due to impaired nutritional status, avoidance of sunlight during prolonged hospitalization, cytotoxic therapy, and radiation, and Vitamin D deficiency is a risk factor for unfavorable outcomes following ICU treatment.

In the current study by Buchtele et al.  (1), the researchers found that severe vitamin D deficiency was an independent predictor of hospital mortality and 1-year mortality, but not of ICU mortality. The observed associations of severe vitamin D deficiency and post-ICU outcome warrants further research and clinical consideration.

The full article can be found here.

 

  1. Buchtele N, Lobmeyr E, Cserna J, Zauner C, Heinz G, Sengölge G, et al. Prevalence and Impact of Vitamin D Deficiency in Critically Ill Cancer Patients Admitted to the Intensive Care Unit. Nutrients. 2020;13(1).

News

04-03-2021

Smartfish´s medical nutrition product Remune® to be used in international res ...

18-12-2020

COVID-19 has highlighted the importance of nutrition for a well-functioning i ...

12-11-2020

Researchers investigate whether fish oil including omega-3 and vitamin D can ...

22-10-2020

LIPIDS publishes PREPARE study on intervention with Smartfish´ Marine Omega-3 ...

29-09-2020

Press release: Smartfish partners with the international Public-Private Conso ...

10-09-2020

Press release: First patient recruited in research study investigating the ef ...

20-08-2020

Smartfish welcomes Mari Rivelsrud as our interim International Product Specia ...

18-08-2020

Uno Viberg has been appointed Product Development- and Quality manager of Sma ...

12-06-2020

Press release: In-depth analysis of clinical trial results shows that Smartfi ...

11-06-2020

Press release: New study reports positive results for Smartfish product in pa ...